Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

The American Diabetes Association and the European Association for the Study of Diabetes convened a panel to update the previous consensus statements on the management of hyperglycemia in type 2 diabetes in adults, published since 2006 and last updated in 2019. The results of cardiovascular and kidney outcomes trials involving sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists, including assessment of subgroups, inform broader recommendations for cardiorenal...

⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.

• 1 The target audience is the full spectrum of the professional health care team providing diabetes care in the U.S.
• 2 A systematic examination of publications since 2018 informed new recommendations.
• 3 These include additional focus on social determinants of health, the health care system, and physical activity behaviors, including sleep.

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source: